๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Clinical Features and Current Treatment of Primary Headache
NCT06883955Primary Headache
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
2,000
Guangzhou
2025-03-08
Active, closed
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531Esophageal Malignant Neoplasm Primary
Henan Cancer Hospital
Phase 2
30
Zhengzhou
2025-03-08
Recruiting
Electroacupuncture Treatment for Discogenic Low Back Pain
NCT06703671Discogenic Low Back Pain
Beijing Hospital
Not applicable
240
Beijing
2025-03-08
Recruiting
QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
NCT06951997Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
33
Tianjin
2025-03-07
Active, closed
Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis
NCT06762080Leptomeningeal Metastasis
Guangzhou Medical University
Phase 1/2
36
Huizhou, Beijing, Shanghai
2025-03-07
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
Alexion Pharmaceuticals, Inc.
Phase 2
47
Changsha, Guangzhou, Nanning, Shanghai, Wuhan, Xi'an
2025-03-07
Recruiting
Carotid Endarterectomy and Stenting Timing
NCT06898151Carotid Endarterectomy, Carotid Stenting
Xuanwu Hospital, Beijing
Not applicable
268
Beijing
2025-03-07
Recruiting
Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions
NCT07362914Breast Cancer
Fudan University
Phase 3
182
Shanghai
2025-03-07
Recruiting
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
NCT06844474NSCLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
300
Beijing
2025-03-07
Recruiting
Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients
NCT07145294Cognitive Impairment
Hongmei Wang
Phase 1/2
40
Shanghai
2025-03-07
Not yet open
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
NCT06867406Healthy Subjectsใ€Lipid Metabolism
Kunming Pharmaceuticals, Inc.
Phase 1
92
Beijing
2025-03-07
Recruiting
A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
NCT06796699Advanced Solid Tumors With MTAP Gene Deletion
Suzhou Genhouse Bio Co., Ltd.
Phase 1
90
Beijing, Shanghai, Taiyuan
2025-03-07
Recruiting
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
NCT06880081Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1
12
Guiyang, Nanchang, Jining, Tianjin, Kunming
2025-03-07
Recruiting
Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome
NCT06912282Meige Syndrome
Huashan Hospital
Not applicable
20
Shanghai
2025-03-06
Not yet open
Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis
NCT06797700Spine Degeneration
The First People's Hospital of Yunnan
Observational
1,000
Kunming
2025-03-06
Recruiting
Study of CMTS1215 Injection in Patients With Solid Tumors
NCT07556276Solid Tumor
The Second Hospital of Nanjing Medical University
Phase 1/2
20
Nanjing
2025-03-06
Recruiting
Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors
NCT06823609Advanced Malignant Tumor
Qilu Pharmaceutical Co., Ltd.
Phase 1
180
Shanghai
2025-03-06
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
NCT06772623Non Small Cell Lung Carcinoma
AbbVie
Phase 1/2
252
Beijing, Fuzhou, Liuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2025-03-06
Recruiting
The Mobile-based Training System in Peritoneal Dialysis Patients
NCT06876987Peritoneal Dialysis
China Medical University Hospital
Not applicable
50
2025-03-06
Recruiting
A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06716138Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
Avistone Biotechnology Co., Ltd.
Phase 1
96
Fuzhou, Guangzhou, Shanghai, Chengdu
2025-03-06
Active, closed
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
NCT06855758Kidney Transplant, Delayed Graft Function, Intraoperative Hypotension
Beijing Friendship Hospital
Not applicable
150
Beijing
2025-03-06
Not yet open
Observation on the Curative Effect of Acupuncture At Sensitized Points on Gallbladder Meridian in the Treatment of Neck Type Cervical Spondylopathy
NCT06847945Cervical Spondylopathy
LiChaoran
Not applicable
80
Hangzhou
2025-03-05
Recruiting
Progesterone-modified Natural Cycle for FET
NCT06644794Infertility, Female
Shandong University of Traditional Chinese Medicine
Phase 3
336
Jinan
2025-03-05
Recruiting
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial
NCT06816914Resectable Pancreatic Adenocarcinoma
Taichung Veterans General Hospital
Phase 2
84
2025-03-05
Recruiting
Ultra-processed Food Consumption and Behavioral Disorder and Cognitive Function
NCT07465081ADD/ADHD
China Medical University Hospital
Not applicable
154
2025-03-05
Recruiting
The Parkinson's Disease Case-Control Study
NCT06848192Parkinson Disease
Westlake University
Observational
40
Hangzhou
2025-03-05
Active, closed
Impact of Periodontal Therapy on AF Recurrence Post-Ablation in High-Inflammatory Burden Patients
NCT06892808Atrial Fibrillation, Periodontitis
Xu Liu
Not applicable
212
Shanghai
2025-03-05
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996Mantle Cell Lymphoma, B Cell Lymphoma
BeOne Medicines
Phase 3
300
Beijing, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Xuzhou
2025-03-05
Recruiting
Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia
NCT07571096Polycystic Ovary Syndrome (PCOS), Thrombophilia
Guangdong Women and Children Hospital
Observational
100
Guangzhou
2025-03-04
Recruiting
Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
NCT06964906ER+/HER2- Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2025-03-04
Recruiting
Metformin Hydrochloride Sustained-release Tablets (โ…ข) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
NCT06932874Atherosclerotic Heart Disease, Type 2 Diabetes
China National Center for Cardiovascular Diseases
Phase 4
356
Beijing
2025-03-04
Recruiting
EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors
NCT06541639Advanced or Recurrent Solid Tumors
Peking University
Phase 1
78
Beijing, Shanghai
2025-03-04
Recruiting
The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease
NCT06765499Motor Neuron Disease (MND), Amyotrophic Lateral Sclerosis (ALS)
First People's Hospital of Hangzhou
Not applicable
100
Hangzhou
2025-03-04
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06955988Locally Advanced or Metastatic Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc.
Phase 1
120
Shanghai
2025-03-04
Recruiting
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
NCT06688435Myasthenia Gravis
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
60
Jinan
2025-03-04
By invitation
Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients
NCT07108179Critically Ill Patients
Sinocare
Observational
120
Changsha
2025-03-04
Recruiting
The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
NCT06742788Infertility Assisted Reproductive Technology
Xijing Hospital
Not applicable
90
Xi'an
2025-03-04
By invitation
Intervention Program for Alarm Fatigue in NICU Nurses Based on ABC-X Model
NCT07025863Alert Fatigue, Health Personnel
Guizhou Medical University
Not applicable
33
Guiyang
2025-03-03
Recruiting
Clinical Study on the Safety and Efficacy of BCMA-CARTยฑASCT in Treating Young Multiple Myeloma Patients
NCT07169500Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
50
Tianjin
2025-03-03
Recruiting
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
NCT06838949Herombopag
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
80
Tianjin
2025-03-03
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
AstraZeneca
Phase 3
5,000
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan
2025-03-03
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
NCT06742892Carcinoma, Hepatocellular
Shanghai Henlius Biotech
Phase 2
90
Hunan
2025-03-03
Recruiting
Reproductive and Mental Health of Patients With Aplastic Anemia
NCT06936930Aplastic Anemia, Reproductive Health
Institute of Hematology & Blood Diseases Hospital, China
Observational
600
Tianjin
2025-03-03
Active, closed
Blended Cardiac Rehabilitation Training for Cardiology Residents
NCT07755878Medical Education, Cardiac Rehabilitation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
98
Hangzhou
2025-03-03
Recruiting
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
NCT07109323Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm Definitions, Cytogenetics Ultra High Risk, Primary Refractory, Early Progression
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
50
Tianjin
2025-03-03
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Recruiting
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
NCT06783049Ischemic Stroke, Transient Ischemic Attack (TIA)
Beijing Tiantan Hospital
Not applicable
4,490
Beijing, Shihezi
2025-03-03
Recruiting
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
NCT06848400Gastric Lesion, Gastritis, Upper Gastrointestinal Bleeding (UGIB), Gastric Dysplasia
Nanfang Hospital, Southern Medical University
Not applicable
482
Guangzhou, Shaoguan, Shenzhen, Zhuhai, Wuxi, Ganzhou, Mianyang
2025-03-03
Recruiting
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
NCT06799611Immune Thrombocytopenia (ITP), Treatment
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2025-03-03
Recruiting
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
NCT06882057Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China
Phase 2/3
3,000
Hefei, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Wuhan, Changsha
2025-03-03
Recruiting
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions
NCT06822712Coronary Arterial Disease (CAD)
BrosMed Medical Co., Ltd
Not applicable
250
Lanzhou
2025-03-03
Recruiting
Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model
NCT06880419Acute Graft-versus-Host Disease
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
174
Tianjin
2025-03-03
Not yet open
Study on the Correlation and Consistency of Measuring Biologic Drug Plasma Concentrations Based on Different Detection Methods
NCT06849739Inflammatory Bowel Diseases
Nanfang Hospital, Southern Medical University
Observational
60
Guangzhou
2025-03-02
By invitation
A Study on Multimodal Prognostic Scoring of Advanced PDAC.
NCT07373691Pancreatic Ductal Adenocarcinoma (PDAC)
RenJi Hospital
Observational
100
Shanghai
2025-03-02
Recruiting
A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
NCT06839131Healthy Participants
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1
94
Shanghai
2025-03-02
Recruiting
A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases
NCT07275736Neurological Autoimmune Diseases
Juventas Cell Therapy Ltd.
Phase EARLY_PHASE1
18
Beijing
2025-03-01
Recruiting
Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
NCT06829134Hypertension, Retroperitoneal Disease
Ruijin Hospital
Not applicable
246
Shanghai
2025-03-01
Not yet open
The Use of Hydrogen Ion Water (Shan Shang Water) in the Treatment of Allergic Rhinitis
NCT06756243Allergic Rhinitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-03-01
Not yet open
Effectiveness and Safety of InOยฑDLI for Relapsed B-ALL/LBL After Allo-HSCT
NCT06861348Leukemia, Lymphocytic, Acute
First Affiliated Hospital of Zhejiang University
Phase 2
23
Hangzhou
2025-03-01
Active, closed
Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses
NCT06892470Cataract
Wenzhou Medical University
Observational
62
Hanzhou
2025-03-01
Recruiting
Study of SYH2062 Injection in Healthy Chinese Volunteers
NCT06842537Healthy Chinese Volunteers
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 1
46
Beijing
2025-03-01
Not yet open
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
NCT06863441T-NK Cell Lymphoma
Ruijin Hospital
Observational
50
Shanghai
2025-03-01
Recruiting
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
NCT06564545Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University
Phase 2
276
Zhengzhou
2025-03-01
By invitation
A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer
NCT06936488MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients
Huai'an First People's Hospital
Not applicable
35
Huai'an
2025-03-01
Recruiting
The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.
NCT06851299Metastatic Triple-negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
60
Guangzhou
2025-03-01
Not yet open
Effect of Digital Therapeutics for Cardiac Rehabilitation in Patients With Acute Myocardial Infarction
NCT06772337Acute Myocardial Infarction, Cardiac Rehabilitation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
160
Nanjing
2025-03-01
Recruiting
A Phase โ…ข Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
NCT06764875HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Phase 3
840
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou
2025-03-01
Active, closed
High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis
NCT06897384Severe Acute Pancreatitis
Ruijin Hospital
Not applicable
388
Shanghai
2025-03-01
Not yet open
Validation Study of Simplified Chinese Version of LOTCA Scale in the Assessment of Cognitive Impairment in Patients with Traumatic Brain Injury
NCT06850584Traumatic Brain Injury
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Active, closed
Adjunctive Yu-Tone Music Therapy for Systemic Lupus Erythematosus: a Prospective Cohort Study
NCT06898489Systemic Lupus Erythematosus, Music Therapy
Yijun Luo
Observational
160
Hangzhou
2025-03-01
Not yet open
AI-based Low Dose CBCT Reconstruction for Clinical Application
NCT06831617Lung Nodule
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
400
Wuhan
2025-03-01
Recruiting
taVNS Effects on Fear Ratings in Naturalistic Context
NCT06975124Healthy Participants
University of Electronic Science and Technology of China
Phase 1
70
Chengdu
2025-03-01
By invitation
Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study
NCT06843681Breast Carcinoma in Situ
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
54
Guangzhou
2025-03-01
Recruiting
Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
NCT06864975Hemophilia a with Inhibitor
Runhui WU
Phase 4
110
Beijing
2025-03-01
Recruiting
A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.
NCT06839547Advanced Breast Cancer Brain Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
100
Beijing
2025-03-01
Recruiting
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
NCT07188077Primary Central Nervous System Lymphoma (PCNSL), Diffuse Large B-Cell Lymphoma
Ting YANG
Observational
20
Fuzhou
2025-03-01
Recruiting
Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
NCT06687408Lung Cancer, Non-Small Cell
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
450
Hangzhou, Shanghai
2025-03-01
Recruiting
Multimodal AI-Guided Recovery Management After Lung Cancer Surgery
NCT07588737Postoperative Care, Rehabilitation, Artificial Intelligence (Al), Randomized Controlled Trial (RCT)
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
868
Guangzhou
2025-03-01
Recruiting
Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation
NCT06842147Atrial Fibrillation (AF)
Beijing Anzhen Hospital
Not applicable
15,360
Zhejiang
2025-03-01
Recruiting
Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
NCT06849167Non-Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2
63
Beijing
2025-03-01
Not yet open
Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
NCT06848920Differentiated Thyroid Carcinoma (DTC), Neoadjuvant Therapy
Zhejiang University
Phase 2
20
Hangzhou
2025-03-01
Recruiting
A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases
NCT06901817Leptomeningeal Metastasis
Shanghai Cancer Hospital, China
Phase 2
97
Shanghai
2025-03-01
Recruiting
Perioperative Immunotherapy for Resectable Limited-Stage SCLC
NCT07109401Perioperative Immunotherapy, Limited Stage Lung Small Cell Carcinoma, Resectable Small Cell Lung Cancer
Fudan University
Phase 2
37
Shanghai
2025-03-01
Recruiting
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509Esophageal Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,450
Guangzhou, Nanchang, Shenyang, Jinan, Shanghai
2025-03-01
Recruiting
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
NCT06998875Primary Cutaneous Amyloidosis
Army Medical University, China
Phase 4
56
Chongqing
2025-03-01
Recruiting
Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air
NCT06968234Cirrhosis, Microbiota, Breath Tests
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-03-01
Recruiting
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
NCT06859190Cancer, Insomnia
Qinghai Red Cross Hospital
Phase 3
60
Xining
2025-03-01
Recruiting
Visual Adaptation and Quality of Life After Different IOL Implantation Strategies
NCT07740590Cataract, Aphakia - Lens Capsule Present
Sichuan Academy of Medical Sciences
Observational
264
Chengdu
2025-03-01
Not yet open
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070Thrombosis, Acute Ischemic Stroke (AIS)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
390
Hangzhou
2025-03-01
Active, closed
Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy
NCT06784479Sedative Effect During Drug-induced Sleep Endoscopy, Obstructive Sleep Apnea (OSA)
Dan Liu
Phase 4
174
Tianjin
2025-03-01
Not yet open
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
NCT06849011Stroke Acute, Encephalitis, Non-traumatic Brain Injury
Yan Zhang
Observational
1,185
Beijing, Lanzhou, Guiyang, Zunyi, Tangshan, Shijiazhuang, Hohhot, Suzhou
2025-03-01
Recruiting
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
NCT06521866Advanced Colorectal Carcinoma, Immunotherapy
Fudan University
Phase 2
208
Fuzhou, Xiamen, Lanzhou, Zhengzhou, Huaian, Jinan, Taian, Shanghai
2025-03-01
Not yet open
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
NCT06788171Colorectal Cancer Liver Metastasis
Fujian Cancer Hospital
Phase 2
35
Fuzhou
2025-03-01
Recruiting
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
NCT07050537Fertility Issues, Blastocyst IVF, Embryo Culture
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xiโ€™an
2025-03-01
Recruiting
Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia
NCT06853431Preoperative Anxiety, Preoperative Sedation, Children, Dexmedetomidine
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
80
Wenzhou
2025-03-01
Not yet open
CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair
NCT06814210Mitral Regurgitation, Functional Mitral Regurgitation, Degenerative Mitral Valve Regurgitation
Xiao-dong Zhuang
Not applicable
120
Guangzhou
2025-03-01
By invitation
Comparative Study of Rotational Cryobiopsy Needle and Automated Biopsy Needle in Transthoracic Biopsy Diagnosing Peripheral Pulmonary Lesions
NCT07772479Peripheral Pulmonary Lesions (PPLs), Pulmonary Nodules
Beijing Chao Yang Hospital
Not applicable
308
Beijing
2025-03-01
Not yet open
Risk Prediction Model of MACE in Patients With AMI Based on Multi-modal Machine Learning
NCT06767852Acute Myocardial Infarction
The First Affiliated Hospital with Nanjing Medical University
Observational
655
Nanjing
2025-03-01
Recruiting
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
NCT06564493Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University
Phase 2
170
Zhengzhou
2025-03-01
Recruiting
Trop-2 Targeted PET Probes in Advanced TNBC
NCT07046455TNBC - Triple-Negative Breast Cancer
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2025-03-01
Rows per page Showing 9101–9200 of 19052
Previous 90 91 92 93 94 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=92

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.